These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7697369)

  • 1. An immunohistochemical study of cathepsin E in Alzheimer-type dementia brains.
    Bernstein HG; Wiederanders B
    Brain Res; 1994 Dec; 667(2):287-90. PubMed ID: 7697369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin.
    Cataldo AM; Thayer CY; Bird ED; Wheelock TR; Nixon RA
    Brain Res; 1990 Apr; 513(2):181-92. PubMed ID: 2350688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of choline acetyltransferase activity between the nucleus basalis of Meynert and the cerebral cortex.
    Koshimura K; Kato T; Yohyama I; Nakamura S; Kameyama M
    Neurosci Res; 1987 Apr; 4(4):330-6. PubMed ID: 3601249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues.
    Nakanishi H; Tominaga K; Amano T; Hirotsu I; Inoue T; Yamamoto K
    Exp Neurol; 1994 Mar; 126(1):119-28. PubMed ID: 8157122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer dementia and reduced nicotinamide adenine dinucleotide (NADH)-diaphorase activity in senile plaques and the basal forebrain.
    Jacobs RW; Farivar N; Butcher LL
    Neurosci Lett; 1985 Jan; 53(1):39-44. PubMed ID: 3838807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal proteinases as putative diagnostic tools in human neuropathology: Alzheimer disease (AD) and schizophrenia.
    Bernstein HG; Kirschke H; Wiederanders B; Khudoerkov RM; Hinz W; Rinne A
    Acta Histochem Suppl; 1992; 42():19-24. PubMed ID: 1584965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia.
    Allen JM; Ferrier IN; Roberts GW; Cross AJ; Adrian TE; Crow TJ; Bloom SR
    J Neurol Sci; 1984 Jun; 64(3):325-31. PubMed ID: 6147394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of manganese superoxide dismutase in the cerebral cortex and hippocampus of Alzheimer-type senile dementia.
    Maeda M; Takagi H; Hattori H; Matsuzaki T
    Osaka City Med J; 1997 Jun; 43(1):1-5. PubMed ID: 9343989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lysosomal cysteine protease, cathepsin S, is increased in Alzheimer's disease and Down syndrome brain. An immunocytochemical study.
    Lemere CA; Munger JS; Shi GP; Natkin L; Haass C; Chapman HA; Selkoe DJ
    Am J Pathol; 1995 Apr; 146(4):848-60. PubMed ID: 7717452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients.
    Henke H; Lang W
    Brain Res; 1983 May; 267(2):281-91. PubMed ID: 6871677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient forebrain ischemia induces increased expression and specific localization of cathepsins E and D in rat hippocampus and neostriatum.
    Nakanishi H; Tsukuba T; Kondou T; Tanaka T; Yamamoto K
    Exp Neurol; 1993 Jun; 121(2):215-23. PubMed ID: 8339772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
    Lippa CF; Smith TW; Perry E
    J Neural Transm (Vienna); 1999; 106(5-6):525-35. PubMed ID: 10443555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.
    Furuta A; Price DL; Pardo CA; Troncoso JC; Xu ZS; Taniguchi N; Martin LJ
    Am J Pathol; 1995 Feb; 146(2):357-67. PubMed ID: 7856748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain.
    Cataldo AM; Nixon RA
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3861-5. PubMed ID: 1692625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 1-trypsin immunoreactivity in Alzheimer disease.
    Smith MA; Kalaria RN; Perry G
    Biochem Biophys Res Commun; 1993 Jun; 193(2):579-84. PubMed ID: 8512558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease.
    Cataldo AM; Paskevich PA; Kominami E; Nixon RA
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):10998-1002. PubMed ID: 1837142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic expression of cathepsin B in aged human brain.
    Bernstein HG; Kirschke H; Wiederanders B; Schmidt D; Rinne A
    Brain Res Bull; 1990 Apr; 24(4):543-9. PubMed ID: 2357585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P immunoreactivity in Alzheimer disease: a study in cases presenting symmetric or asymmetric cortical atrophy.
    Bouras C; Vallet PG; Hof PR; Charnay Y; Golaz J; Constantinidis J
    Alzheimer Dis Assoc Disord; 1990; 4(1):24-34. PubMed ID: 1690554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative localization of ADAMs 10 and 15 in human cerebral cortex normal aging, Alzheimer disease and Down syndrome.
    Bernstein HG; Bukowska A; Krell D; Bogerts B; Ansorge S; Lendeckel U
    J Neurocytol; 2003 Feb; 32(2):153-60. PubMed ID: 14707550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons.
    Yermakova AV; Rollins J; Callahan LM; Rogers J; O'Banion MK
    J Neuropathol Exp Neurol; 1999 Nov; 58(11):1135-46. PubMed ID: 10560656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.